{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-000117","form_type":"8-K","ticker":"IRMD","cik":"0001325618","company_name":"IRADIMED CORP","filed_at":"2025-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.293072+00:00","generated_at":"2026-05-28T04:34:25.480116+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"iRadimed Q4 2024 revenue range $19.2-$19.4M, record; full-year revenue $73.1-$73.3M, up 11-12% YoY","bullets":["Q4 2024 revenue ~$19.2M-$19.4M, a record; YoY growth 10-11%, sequential growth 5-6%.","Full-year 2024 revenue ~$73.1M-$73.3M vs $65.6M in 2023, YoY growth 11-12%.","Orders booked in Q4 exceeded shipments, building robust backlog for 2025.","CEO Roger Susi cites increasing demand expected to continue through 2025.","Company to present at J.P. Morgan Healthcare Conference on Jan 15, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-000117","json":"https://secwatch.observer/filing/0001558370-25-000117.json","markdown":"https://secwatch.observer/filing/0001558370-25-000117.md","text":"https://secwatch.observer/filing/0001558370-25-000117.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1325618/000155837025000117/0001558370-25-000117-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1325618/000155837025000117/irmd-20250110x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T04:34:25.480116+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}